Cardionomic Overview

  • Year Founded
  • 2012

Year Founded

  • Status
  • Private

  • Employees
  • 17

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $5M

  • Investors
  • 4

Cardionomic General Information

Description

Developer of a cardiac therapy device designed to treat acute decompensated heart failure. The company's therapy addresses the condition's root cause of reduced contractility using neuromodulation to increase contractility, improve cardiac output and increase renal flow or end-organ perfusion, enabling healthcare practitioners to decrease negative hormonal signaling and improve in-hospital morbidity and mortality.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Therapeutic Devices
Other Industries
Surgical Devices
Other Healthcare Technology Systems
Corporate Office
  • 601 Campus Drive
  • Suite 12
  • New Brighton, MN 55112
  • United States
+1 (651) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Cardionomic Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Later Stage VC 04-Oct-2021 $5M 000.00 Completed Clinical Trials - Phase 2
4. Later Stage VC (Series A2) 21-Feb-2020 000.00 000.00 000.00 Completed Clinical Trials - Phase 2
3. Later Stage VC (Series A1) 30-Apr-2018 000 000.00 000.00 Completed Clinical Trials - Phase 2
2. Early Stage VC (Series A) 02-Oct-2015 $20M $22.4M Completed Clinical Trials - Phase 1
1. Early Stage VC (Series A) 01-Apr-2014 $2.35M $2.35M Completed Clinical Trials - Phase 1
To view Cardionomic’s complete valuation and funding history, request access »

Cardionomic Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A2 00,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.000
Series A2 (NV) 0,000,000 00.000000 00.00 00.00 00.00 00 00.00 00
Series A1 (NV) 5,439,215 $0.001000 $0.12 $1.47 $1.47 1x $1.47 0%
Series A1 18,786,541 $0.001000 $0.13 $1.63 $1.63 1x $1.63 46.63%
To view Cardionomic’s complete cap table history, request access »

Cardionomic Patents

Cardionomic Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4164737-A1 Chronically implantable systems and methods for affecting cardiac contractility and/or relaxation Pending 16-Jun-2020 00000000000
AU-2021293019-A1 Chronically implantable systems and methods for affecting cardiac contractility and/or relaxation Pending 16-Jun-2020 00000000000
CA-3181526-A1 Chronically implantable systems and methods for affecting cardiac contractility and/or relaxation Pending 16-Jun-2020 00000000000
US-20230256252-A1 Chronically implantable systems and methods for affecting cardiac contractility and/or relaxation Pending 16-Jun-2020 00000000000
EP-3965639-A1 Systems and methods for denoising physiological signals during electrical neuromodulation Pending 06-May-2019 A61B5/7217
To view Cardionomic’s complete patent history, request access »

Cardionomic Executive Team (5)

Name Title Board Seat Contact Info
Steve Goedeke Founder, Chief Executive Officer, President & Board Member
Julio Spinelli Chief Scientific Officer
Michelle Kennefick Vice President of Clinical Research
You’re viewing 3 of 5 executive team members. Get the full list »

Cardionomic Board Members (16)

Name Representing Role Since
Ali Behbahani MD New Enterprise Associates Board Member 000 0000
Andrew Senn Integer Board Member 000 0000
Anthony Borowicz Integer Board Member 000 0000
Brian Farley Self Board Member 000 0000
Jon Friedland Self Board Member 000 0000
You’re viewing 5 of 16 board members. Get the full list »

Cardionomic Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Cardionomic Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Cleveland Clinic Ventures Corporate Venture Capital Minority 000 0000 000000 0
Ascension Ventures Corporate Venture Capital Minority 000 0000 000000 0
Integer Corporation Minority 000 0000 000000 0
New Enterprise Associates Venture Capital Minority 000 0000 000000 0
To view Cardionomic’s complete investors history, request access »

Cardionomic FAQs

  • When was Cardionomic founded?

    Cardionomic was founded in 2012.

  • Who is the founder of Cardionomic?

    Steve Goedeke is the founder of Cardionomic.

  • Who is the CEO of Cardionomic?

    Steve Goedeke is the CEO of Cardionomic.

  • Where is Cardionomic headquartered?

    Cardionomic is headquartered in New Brighton, MN.

  • What is the size of Cardionomic?

    Cardionomic has 17 total employees.

  • What industry is Cardionomic in?

    Cardionomic’s primary industry is Therapeutic Devices.

  • Is Cardionomic a private or public company?

    Cardionomic is a Private company.

  • What is Cardionomic’s current revenue?

    The current revenue for Cardionomic is 000000.

  • How much funding has Cardionomic raised over time?

    Cardionomic has raised $52.2M.

  • Who are Cardionomic’s investors?

    Cleveland Clinic Ventures, Ascension Ventures, Integer, and New Enterprise Associates have invested in Cardionomic.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »